Clinical Trials Browser

Phase 1/2 × Glioblastoma × avelumab × Clear all

NCT03750071 2022-10-20

VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma

Phase 1/2 Unknown

Glioblastoma